How to cite this WIREs title:
WIREs Membr Transp Signal

Metabotropic glutamate receptors and cancerous growth

Focus Article

Jessica Teh, Suzie Chen

Published Online: Oct 25 2011

DOI: 10.1002/wmts.21

How to cite this article
Download citation
Contact the editor about this article
Authors: submit updates and notes
Comment on this article
Share

Full article on Wiley Online Library: HTML PDF

Can't access this content? Tell your librarian.

G‐protein‐coupled receptors (GPCRs) represent a class of therapeutic targets that have been widely exploited for drug designs and development. Metabotropic glutamate receptors (mGluRs) belong to Class C GPCRs and are predominantly involved in maintaining cellular homeostasis in the central nervous system (CNS). The surprising accumulating evidence suggesting other functional roles of mGluRs in human malignancies in addition to synaptic transmission has presented intriguing possibilities to make mGluRs putative novel targets for human cancers. Since our group first described the aberrant expression of mGluR1 as the driving force in melanomagenesis in transgenic mouse models, other subtypes of mGluRs have been implicated in the pathogenesis of various cancer types such as malignant gliomas and medulloblastomas. As such, increased efforts have been generated to elucidate the mechanisms by which mGluRs confer oncogenic potential. Current knowledge on the participation of various mGluRs in several human cancers suggests that mGluRs are ‘druggable’ members of the GPCR superfamily and their oncogenic implications in cancer, so further understanding on anti‐mGluR strategies will be beneficial. WIREs Membr Transp Signal 2012, 1:211–220. doi: 10.1002/wmts.21

References

1 Hollmann, M, Heinemann, S. Cloned glutamate receptors. Annu Rev Neurosci 1994, 17:31–108.
2 Skerry, TM, Genever, PG. Glutamate signalling in non‐neuronal tissues. Trends Pharmacol Sci 2001, 22:174–181.
3 Frati, C, Marchese, C, Fisichella, G, Copani, A, Nasca, MR, Storto, M, Nicoletti, F. Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J Cell Physiol 2000, 183:364–372.
4 Genever, PG, Maxfield, SJ, Kennovin, GD, Maltman, J, Bowgen, CJ, Raxworthy, MJ, Skerry, TM. Evidence for a novel glutamate‐mediated signaling pathway in keratinocytes. J Invest Dermatol 1999, 112:337–342.
5 Gill, SS, Pulido, OM, Mueller, RW, McGuire, PF. Immunochemical localization of the metabotropic glutamate receptors in the rat heart. Brain Res Bull 1999, 48:143–146.
6 Melchiorri, D, Cappuccio, I, Ciceroni, C, Spinsanti P, Mosillo P, Sarichelou I, Sale P, Nicoletti F. Metabotropic glutamate receptors in stem/progenitor cells. Neuropharmacology 2007, 53:473–480.
7 Morimoto, R, Uehara, S, Yatsushiro, S, Juge, N, Hua, Z, Senoh, S, Echigo, N, Hayashi, M, Mizoguchi, T, Ninomiya, T, et al. Secretion of L‐glutamate from osteoclasts through transcytosis. EMBO J 2006, 20:4175–4186.
8 Storto, M, Capobianco, L, Battaglia, G, Molinaro, G, Gradini, R, Riozzi, B, Di Mambro, A, Mitchell, KJ, Bruno, V, Vairetti, MP, et al. Insulin secretion is controlled by mGlu5 metabotropic glutamate receptors. Mol Pharmacol 2006, 69:1234–1241.
9 Storto, M, de Grazia, U, Knopfel, T, Canonico, PL, Copani, A, Richelmi, P, Nicoletti, F, Vairetti, M. Selective blockade of mGlu5 metabotropic glutamate receptors protects rat hepatocytes against hypoxic damage. Hepatology 2000, 31:649–655.
10 Hollmann, M, O`Shea‐Greenfield, A, Rogers, SW, Heinemann, S. Cloning by functional expression of a member of the glutamate receptor family. Nature 1989, 342:643–648.
11 Traynelis, SF, Wollmuth, LP, McBain, CJ, Menniti, FS, Vance, KM, Ogden, KK, Hansen, KB, Yuan, H, Myers, SJ, Dingledine, R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010, 62:405–496.
12 Hermans, E, Challiss, RA. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G‐protein‐coupled receptors. Biochem J 2001, 1(Pt 3):465–484.
13 Marinissen, MJ, Gutkind, JS. G‐protein‐coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001, 22:368–376.
14 Dorsam, RT, Gutkind, JS. G‐protein‐coupled receptors and cancer. Nat Rev Cancer 2007, 7:79–94.
15 Sladeczek, F, Pin, JP, Recasens, M, Bockaert, J, Weiss, S. Glutamate stimulates inositol phosphate formation in striatal neurones. Nature 1985, 317:24–30.
16 Masu, M, Tanabe, Y, Tsuchida, K, Shigemoto, R, Nakanishi, S. Sequence and expression of a metabotropic glutamate receptor. Nature 1991, 28:760–765.
17 Niswender, CM, Conn, PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010, 50:295–322.
18 Aiba, A, Kano, M, Chen, C, Stanton, ME, Fox, GD, Herrup, K, Zwingman, TA, Tonegawa, S. Deficient cerebellar long‐term depression and impaired motor learning in mGluR1 mutant mice. Cell 1994, 21:377–388.
19 Levenes, C, Daniel, H, Jaillard, D, Conquet, F, Crepel, F. Incomplete regression of multiple climbing fibre innervation of cerebellar Purkinje cells in mGLuR1 mutant mice. Neuroreport 1997, 8:571–574.
20 Higgins, GA, Ballard, TM, Kew, JN, Richards, JG, Kemp, JA, Adam, G, Woltering, T, Nakanishi, S, Mutel, V. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 2004, 46:907–917.
21 Corti, C, Battaglia, G, Molinaro, G, Riozzi, B, Pittaluga, A, Corsi, M, Mugnaini, M, Nicoletti, F, Bruno, V. The use of knock‐out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. J Neurosci 2007, 1:8297–8308.
22 Yoneda, Y, Ogita, K. [3H]glutamate binding sites in the rat pituitary. Neurosci Res 1986, 3:430–435.
23 Yoneda, Y, Ogita, K. Localization of [3H]glutamate binding sites in rat adrenal medulla. Brain Res 1986, 24:387–391.
24 Gu, Y, Publicover, SJ. Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. Cross‐talk with N‐methyl‐D‐aspartate receptors. J Biol Chem 2000, 3:34252–34259.
25 Stepulak, A, Luksch, H, Gebhardt, C, Uckermann, O, Marzahn, J, Sifringer, M, Rzeski, W, Staufner, C, Brocke, KS, Turski, L, et al. Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 2009, 132:435–445.
26 Brocke, KS, Staufner, C, Luksch, H, Geiger, KD, Stepulak, A, Marzahn, J, Schacker, G, Temme, A, Ikonomidou, C. Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol Ther 2010, 9:455–468.
27 Seidlitz, EP, Sharma, MK, Saikali, Z, Ghert, M, Singh, G. Cancer cell lines release glutamate into the extracellular environment. Clin Exp Metastasis 2009, 26:781–787.
28 Sharma, MK, Seidlitz, EP, Singh, G. Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun 2010, 391:91–95.
29 Seidlitz, EP, Sharma, MK, Singh, G. Extracellular glutamate alters mature osteoclast and osteoblast functions. Can J Physiol Pharmacol 2010, 88:929–936.
30 Pollock, PM, Cohen‐Solal, K, Sood, R, Namkoong, J, Martino, JJ, Koganti, A, Zhu, H, Robbins, C, Makalowska, I, Shin, SS, et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003, 34:108–112.
31 Speyer, CL, Smith, JS, Banda, M, Devries, JA, Mekani, T, Gorski, DH. Metabotropic glutamate receptor‐1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 2011.
32 Park, SY, Lee, SA, Han, IH, et al. Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep 2007, 17:81–87.
33 Kalariti, N, Lembessis, P, Papageorgiou, E, Pissimissis, N, Koutsilieris, M. Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG‐63 osteoblast‐like osteosarcoma cells. J Musculoskelet Neuronal Interact 2007, 7:113–118.
34 Pissimissis, N, Papageorgiou, E, Lembessis, P, Armakolas, A, Koutsilieris, M. The glutamatergic system expression in human PC‐3 and LNCaP prostate cancer cells. Anticancer Res 2009, 29:371–377.
35 Aleman, MMA, Harsch, KM, Detore, N, Klein, E, Heston, WDW. Expression of metabotropic glutamate receptors in human prostate cancers and its potential signaling through prostate specific membrane antigen. Proc Am Assoc Cancer Res 2004, 45:1196.
36 D`Onofrio, M, Arcella, A, Bruno, V, Ngomba, RT, Battaglia, G, Lombari, V, Ragona, G, Calogero, A, Nicoletti, F. Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. J Neurochem 2003, 84:1288–1295.
37 Arcella, A, Carpinelli, G, Battaglia, G, D`Onofrio, M, Santoro, F, Ngomba, RT, Bruno, V, Casolini, P, Giangaspero, F, Nicoletti, F. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro Oncol 2005, 7:236–245.
38 Ciceroni, C, Arcella, A, Mosillo, P, Battaglia, G, Mastrantoni, E, Oliva, MA, Carpinelli, G, Santoro, F, Sale, P, Ricci‐Vitiani, L, et al. Type‐3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma‐initiating cells. Neuropharmacology 2008, 55:568–576.
39 Chang, HJ, Yoo, BC, Lim, SB, Jeong, SY, Kim, WH, Park, JG. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res 2005, 1:3288–3295.
40 Iacovelli, L, Arcella, A, Battaglia, G, Pazzaglia, S, Aronica, E, Spinsanti, P, Caruso, A, De Smaele, E, Saran, A, Gulino, A, et al. Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci 2006, 9:8388–8397.
41 Chen, S, Teicher, LC, Kazim, D, Pollack, RE, Wise, LS. Commitment of mouse fibroblasts to adipocyte differentiation by DNA transfection. Science 1989, 5:582–585.
42 Chen, S, Zhu, H, Wetzel, WJ, Philbert, MA. Spontaneous melanocytosis in transgenic mice. J Invest Dermatol 1996, 106:1145–1151.
43 Zhu, H, Reuhl, K, Zhang, X, Botha, R, Ryan, K, Wei, J, Chen, S. Development of heritable melanoma in transgenic mice. J Invest Dermatol 1998, 110:247–252.
44 Marin, YE, Namkoong, J, Shin, SS, Raines, J, Degenhardt, K, White, E, Chen, S. Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes. Neuropharmacology 2005, 49(suppl 1):70–79.
45 Ohtani, Y, Harada, T, Funasaka, Y, Nakao, K, Takahara, C, Abdel‐Daim, M, Saka, N, Saito, N, Nishigori, C, Aiba, A. Metabotropic glutamate receptor subtype‐1 is essential for in vivo growth of melanoma. Oncogene 2008, 27:7162–7170.
46 Julius, D, Livelli, TJ, Jessell, TM, Axel, R. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 1989, 244:1057–1062.
47 Gutkind, JS. Cell growth control by G protein‐coupled receptors: from signal transduction to signal integration. Oncogene 1998, 17:1331–1342.
48 Allen, LF, Lefkowitz, RJ, Caron, MG, Cotecchia, S. G‐protein‐coupled receptor genes as protooncogenes: constitutively activating mutation of the α 1B‐adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci U S A 1991, 88:11354–11358.
49 Bais, C, Santomasso, B, Coso, O, Arvanitakis, L, Raaka, EG, Gutkind, JS, Asch, S, Cesarman, E, Gershengorn, MC, Mesri, EA. G‐protein‐coupled receptor of Kaposi`s sarcoma‐associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998, 391:86–89.
50 Dhanasekaran, N, Tsim, ST, Dermott, JM, Onesime, D. Regulation of cell proliferation by G proteins. Oncogene 1998, 17:1383–1394.
51 Hermouet, S, Aznavoorian, S, Spiegel, AM. In vitro and in vivo growth inhibition of murine melanoma K‐1735 cell by a dominant negative mutant α subunit of the Gi2 protein. Cell Signal 1996, 8:159–166.
52 Montaner, S, Sodhi, A, Molinolo, A, Bugge, TH, Sawai, ET, He, Y, Li, Y, Ray, PE, Gutkind, JS. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi`s sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 2003, 3:23–36.
53 Namkoong, J, Shin, SS, Lee, HJ, Marin, YE, Wall, BA, Goydos, JS, Chen, S. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 2007, 67:2298–2305.
54 Funasaka, YHT, Aiba, A, Nishigori, C. Expression of metabotropic glutamate receptor 1 and phosphorylated extracellular signal‐regulated kinase 1/2 proteins in human melanocytic lesions. Pigment Cell Melanoma Res 2006, 19:656.
55 Shin, SS, Namkoong, J, Wall, BA, Gleason, R, Lee, HJ, Chen, S. Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res 2008, 21:368–378.
56 Shin, SS, Wall, BA, Goydos, JS, Chen, S. AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res 2010, 23:103–111.
57 Stahl, JM, Sharma, A, Cheung, M, Zimmerman, M, Cheng, JQ, Bosenberg, MW, Kester, M, Sandirasegarane, L, Robertson, GP. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 2004, 1:7002–7010.
58 Nogueira, C, Kim, KH, Sung, H, Paraiso, KH, Dannenberg, JH, Bosenberg, M, Chin, L, Kim, M. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene 2010, 25:6222–6232.
59 Cheah, BC, Vucic, S, Krishnan, AV, Kiernan, MC. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 2010, 17:1942–1199.
60 Yip, D, Le, MN, Chan, JL, Lee, JH, Mehnert, JA, Yudd, A, Kempf, J, Shih, WJ, Chen, S, Goydos, JS. A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res 2009, 15:3896–3902.
61 Biechele, TL, Camp, ND, Fass, DM, Kulikauskas, RM, Robin, NC, White, BD, Taraska, CM, Moore, EC, Muster, J, Karmacharya, R, et al. Chemical‐genetic screen identifies riluzole as an enhancer of Wnt/β‐catenin signaling in melanoma. Chem Biol 2010, 24:1177–1182.
62 Chien, AJ, Moore, EC, Lonsdorf, AS, Kulikauskas, RM, Rothberg, BG, Berger, AJ, Major, MB, Hwang, ST, Rimm, DL, Moon, RT. Activated Wnt/β‐catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A 2009, 106:1193–1198.
63 Degenhardt, K, White, E. A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin Cancer Res 2006, 15:5298–5304.
64 Louis, DN, Ohgaki, H, Wiestler, OD, Cavenee, WK, Burger, PC, Jouvet, A, Scheithauer, BW, Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97–109.
65 Ye, ZC, Sontheimer, H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999, 1:4383–4391.
66 Denysenko, T, Gennero, L, Roos, MA, Melcarne, A, Juenemann, C, Faccani, G, Morra, I, Cavallo, G, Reguzzi, S, Pescarmona, G, et al. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies. Cell Biochem Funct 2010, 28:343–351.
67 Gomes, WA, Mehler, MF, Kessler, JA. Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 2003, 255:164–177.
68 Huse, JT, Holland, EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 2010, 10:319–331.
69 Canudas, AM, Di Giorgi‐Gerevini, V, Iacovelli, L, Nano, G, D`Onofrio, M, Arcella, A, Giangaspero, F, Busceti, C, Ricci‐Vitiani, L, Battaglia, G, et al. PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors. J Neurosci 2004, 17:10343–10352.
70 Ye, P, Xing, Y, Dai, Z, D`Ercole, AJ. In vivo actions of insulin‐like growth factor‐I (IGF‐I) on cerebellum development in transgenic mice: evidence that IGF‐I increases proliferation of granule cell progenitors. Brain Res Dev Brain Res 1996, 20:44–54.
71 Dahmane, N, Ruiz i Altaba, A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999, 126:3089–3100.
72 Yokota, N, Nishizawa, S, Ohta, S, Date, H, Sugimura, H, Namba, H, Maekawa, M. Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 2002, 10:198–201.
73 Gilbertson, RJ. Medulloblastoma: signalling a change in treatment. Lancet Oncol 2004, 5:209–218.
74 Pazzaglia, S, Mancuso, M, Atkinson, MJ, Tanori, M, Rebessi, S, Majo, VD, Covelli, V, Hahn, H, Saran, A. High incidence of medulloblastoma following X‐ray‐irradiation of newborn Ptc1 heterozygous mice. Oncogene 2002, 24:7580–7584.
75 Hopkins, CR, Lindsley, CW, Niswender, CM. mGluR4‐positive allosteric modulation as potential treatment for Parkinson`s disease. Future Med Chem 2009, 1:501–513.
76 Yoo, BC, Jeon, E, Hong, SH, Shin, YK, Chang, HJ, Park, JG. Metabotropic glutamate receptor 4‐mediated 5‐fluorouracil resistance in a human colon cancer cell line. Clin Cancer Res 2004, 10(12 Pt 1):4176–4184.
77 Shin, SS, Martino, JJ, Chen, S. Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology 2008, 55:396–402.
78 Cappuccio, I, Spinsanti, P, Porcellini, A, Desiderati, F, De Vita, T, Storto, M, Capobianco, L, Battaglia, G, Nicoletti, F, Melchiorri, D. Endogenous activation of mGlu5 metabotropic glutamate receptors supports self‐renewal of cultured mouse embryonic stem cells. Neuropharmacology 2005, 49(suppl 1):196–205.
79 Spinsanti, P, De Vita, T, Di Castro, S, Storto, M, Formisano, P, Nicoletti, F, Melchiorri, D. Endogenously activated mGlu5 metabotropic glutamate receptors sustain the increase in c‐Myc expression induced by leukaemia inhibitory factor in cultured mouse embryonic stem cells. J Neurochem 2006, 99:299–307.
80 Kalariti, N, Lembessis, P, Koutsilieris, M. Characterization of the glutametergic system in MG‐63 osteoblast‐like osteosarcoma cells. Anticancer Res 2004, 24:3923–3929.
81 Taylor, AF. Osteoblastic glutamate receptor function regulates bone formation and resorption. J Musculoskelet Neuronal Interact 2002, 2:285–290.
82 Wei, X, Walia, V, Lin, JC, Teer, JK, Prickett, TD, Gartner, J, Davis, S, Stemke‐Hale, K, Davies, MA, Gershenwald, JE, et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 2011, 43:442–446.

blog comments powered by Disqus

Article Title	Metabotropic glutamate receptors and cancerous growth
* Name
* E-mail
* Note

Metabotropic glutamate receptors and cancerous growth

Access to this WIREs title is FREE for members of registered institutions.

The latest WIREs articles in your inbox

Metabotropic glutamate receptors and cancerous growth

Browse by Topic

Access to this WIREs title is FREE for members of registered institutions.

The latest WIREs articles in your inbox